$10.60-0.02 (-0.19%)
Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. in the Financial Services sector is trading at $10.60. The stock is currently near its 52-week high of $10.62, remaining 1.8% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more b...